Background: Asthma is one of the most common pulmonary disease worldwide. Asthmatic patients are prone to frequent exacerbation of symptoms that range from cough to severe, disabling shortness of breath, leading to significant impairment of quality of life. Airway obstruction causes increased resistance to airflow and decreased expiratory flow rates. Revolizer is useful for inhaling dry medication powder orally for treating lung-related diseases.Objective: To determine the frequency and comparison of ease-of-use of Revolizer among asthmatic patients who were on metered-dose inhalers (MDIs).Methods: Study Design: Quasi-experimental pre-post design. Setting: Medicine Department, PAEC General hospital Islamabad.Duration: Six months, i.e., 15-10-2024 to 15-4-2025. Data Collection: After meeting the inclusion criteria, 100 patients were enrolled. Then those patients who were using MDIs previously were assorted revolizers and taught about the proper method of using them by investigator. After that, patients were asked to repeat the performance of the inhalation technique in front of the investigator to make sure that the correct method of inhalation is learnt, and the patient was called after 2 weeks for follow-up. Data was entered and analyzed using statistical package for the Social Sciences (v 16.0), which is acceptable for analysis.Results: The mean age of patients was 46.33 9.31 years. There were 48 (48%) males and 52 (52%) females. The ease of use of Revolizer was found in 94 (94%) cases.Conclusion: More than 90% of the patients were in ease of use of Revolizer among asthmatic patients. As compared to MDI, the ease of use was significantly found higher in Revolizer (p 0.001)
Ashfaq et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: